North Polar Tube Reduces the Risk of Epistaxis during Nasotracheal Intubation: A prospective, Randomized Clinical Trial.
Ahmet Seli M Özkan, Sedat Akbas, Erol Toy...
https://pubmed.ncbi.nlm.nih.gov/30787962/Actively Recruiting
Led by Shaheed Mohtarma Benazir Bhutto Institue of Trauma · Updated on 2025-01-30
70
Participants Needed
1
Research Sites
8 weeks
Total Duration
Researchers are comparing the effects of xylometazoline nasal drops and adrenaline nasal packing on nasal bleeding during nasotracheal intubation in participants undergoing elective oromaxillofacial surgeries. The trial aims to determine which of these two treatments better reduces nasal bleeding during the procedure. This study includes participants aged 18 to 60 years with specific health criteria to ensure safety and accuracy. Participants are randomly assigned to one of two groups. One group receives 0.1% xylometazoline nasal drops, administered as 3 to 5 drops in the selected nostril 15 minutes before surgery. The other group receives adrenaline nasal packing, where a gauze soaked in adrenaline is placed inside the nostril 15 minutes before surgery and removed after 7 to 10 minutes. Both groups undergo nasotracheal intubation under general anesthesia with careful monitoring. Throughout the study, participants will have vital signs monitored, including blood pressure, heart rate, ECG, and oxygen saturation. An experienced anesthesiologist will perform the procedures and record the incidence and severity of nasal bleeding during intubation and extubation. Data will be analyzed to compare bleeding outcomes between groups while considering factors like age, gender, and medical history. Participation lasts through the surgical procedure and immediate recovery monitoring.
CONDITIONS
Adrenaline Nasal Pack vs Xylometazoline Nasal Drops During Nasotracheal Intubation
D
Dr Sidra Javed Consultant Anaesthetist, MBBS, FCPS, PAIN FELLOW
D
Dr Mirza Shahzad Baig Consultant Anaesthetist, MBBS, MCPS, FCPS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Shaheed Mohtarma Benazir Bhutto Institue of Trauma
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single day on surgery day
Participants receive either xylometazoline nasal drops or adrenaline nasal packing before nasotracheal intubation during elective oromaxillofacial surgery under general anesthesia.
1 visit (in-person)
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Ahmet Seli M Özkan, Sedat Akbas, Erol Toy...
https://pubmed.ncbi.nlm.nih.gov/30787962/Sonam Patel, Amarjyoti Hazarika, Prachi Agrawal...
https://pubmed.ncbi.nlm.nih.gov/32934988/Jaegyok Song
https://pubmed.ncbi.nlm.nih.gov/29349350/Rosie Earle, Enda Shanahan, Himat Vaghadia...
https://pubmed.ncbi.nlm.nih.gov/28078544/Aiji Sato-Boku, Yoshiki Sento, Yuji Kamimura...
https://pubmed.ncbi.nlm.nih.gov/34592949/Shaheed Mohtarma Benazir Bhutto Institue of Trauma
Lead Sponsor